Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 1/20 | 0.55 |
| ▸ | MMP9 | P14780 | 1/20 | 0.55 |
| ▸ | MMP12 | P39900 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | ALPG | P10696 | 2/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | FFAR1 | O14842 | 4/20 | 0.50 |
| ▸ | LTA4H | P09960 | 1/20 | 0.50 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.47 |
| ▸ | APP | P05067 | 2/20 | 0.46 |
| ▸ | GRM5 | P41594 | 1/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | CES1 | P23141 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7715045 | 0.92 | LTA4H (0.57) | MMP2MMP9MMP12ALDH1A1LMNA | |
| SCHEMBL7717354 | 0.92 | LTA4H (0.57) | MMP2MMP9MMP12ALDH1A1LMNA | |
| SCHEMBL7716924 | 0.92 | LTA4H (0.57) | MMP2MMP9MMP12ALDH1A1LMNA | |
| SCHEMBL13284015 | 0.90 | LMNA (0.49) | MMP2MMP9MMP12ALDH1A1LMNA | |
| SCHEMBL4301156 | 0.88 | L3MBTL1 (0.53) | MMP2MMP9MMP12ALDH1A1LMNA | |
| SCHEMBL1744898 | 0.88 | ALDH1A1 (0.64) | MMP2MMP9MMP12ALDH1A1LMNA | |
| SCHEMBL13284137 | 0.87 | CNR1 (0.51) | MMP2MMP9MMP12ALDH1A1LMNA | |
| SCHEMBL7715052 | 0.86 | ATM (0.46) | MMP2MMP9MMP12ALDH1A1LMNA | |
| SCHEMBL6545360 | 0.86 | ATM (0.46) | MMP2MMP9MMP12ALDH1A1LMNA | |
| SCHEMBL6545581 | 0.84 | HNF4A (0.49) | MMP2MMP9MMP12ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113416127-A | Cross-linkable semi-crystalline polyether-ether-ketone, preparation method and application thereof, polyether-ether-ketone polymer alloy material and preparation method thereof | 吉林大学 | 2021-09-21 | — | — | CN | claimed |
| US-8952200-B2 | Liquid crystal oligomer, synthesis composition, preparation method thereof, and liquid crystal material | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2015-02-10 | — | — | US | claimed |
| US-20120264980-A1 | LIQUID CRYSTAL OLIGOMER, SYNTHESIS COMPOSITION, PREPARATION METHOD THEREOF, AND LIQUID CRYSTAL MATERIAL | BEIJING BOE DISPLAY TECHNOLOGY CO., LTD (CN) | 2012-10-18 | — | — | US | claimed |
| CN-113416127-A | Cross-linkable semi-crystalline polyether-ether-ketone, preparation method and application thereof, polyether-ether-ketone polymer alloy material and preparation method thereof | 吉林大学 | 2021-09-21 | — | — | CN | disclosed |
| US-20210188758-A1 | PHENOXY ACETIC ACIDS AND PHENYL PROPIONIC ACIDS AS PPAR DELTA AGONISTS | VTVX HOLDINGS II LLC | 2021-06-24 | — | — | US | disclosed |
| US-10947180-B2 | Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists | VTV THERAPEUTICS LLC (US) | 2021-03-16 | — | — | US | disclosed |
| US-20200215073-A1 | PHENOXY ACETIC ACIDS AND PHENYL PROPIONIC ACIDS AS PPAR DELTA AGONISTS | HIGH POINT PHARMACEUTICALS, LLC | 2020-07-09 | — | — | US | disclosed |
| EP-3080189-B1 | POLYMERIC MATERIALS | VICTREX MFG LTD (GB) | 2020-02-12 | — | — | EP | disclosed |
| US-10471066-B2 | Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists | VTV THERAPEUTICS LLC (US) | 2019-11-12 | — | — | US | disclosed |
| US-20180071304-A1 | Phenoxy Acetic Acids and Phenyl Propionic Acids as PPAR Delta Agonists | HIGH POINT PHARMACEUTICALS, LLC | 2018-03-15 | — | — | US | disclosed |
| US-9855274-B2 | Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists | VTV THERAPEUTICS LLC (US) | 2018-01-02 | — | — | US | disclosed |
| US-5965687-A | USING A TRIFUNCTIONAL PHENOL IN THE POLYMERIZATION OF POLYETHER MONOMERS TO FORM BRANCHED OR STAR POLYMERS; LOW MELTING POINTS; IMPROVED CHEMICAL RESISTANCE AND MECHANICAL PROPERTIES; RESIN TRANSFER MOLDING AND RESIN FILM INFUSION | THE UNITED STATES OF AMERICA REPRESENTED BY THE ADMINSTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 1999-10-12 | — | — | US | disclosed |
| WO-1998040422-A1 | REDUCED TEMPERATURE CURING OF ACETYLENIC POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1998-09-17 | — | — | WO | disclosed |
| US-5599993-A | USED FOR ENDCAPPING POLYIMIDES WITH EXCELLENT SOLVENT AND CHEMICAL RESISTANCE, HIGH STRENGTH AND MODULUS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 1997-02-04 | — | — | US | disclosed |
| US-5446204-A | Enhance density of thermosetting materials | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 1995-08-29 | — | — | US | disclosed |
| US-5426234-A | Compounds which are heat resistant at lower temperatures, but which polymerize at higher temperatures, also as reactive diluents or end groups for crosslinking | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 1995-06-20 | — | — | US | disclosed |
| US-5412066-A | Adhesives | THER UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 1995-05-02 | — | — | US | disclosed |
| US-5312994-A | Phenylethynyl endcapping reagents and reactive diluents | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 1994-05-17 | — | — | US | disclosed |
| US-5268444-A | Polyketone ethers | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 1993-12-07 | — | — | US | disclosed |
| US-5268444-A | Polyketone ethers | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 1993-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10471066-B2 | Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists | PPARG, PPARA, PPARD | MMP2 3228/4885MMP9 4339/4885MMP12 2672/4885 |
| US-10947180-B2 | Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists | PPARG, PPARA, PPARD | MMP2 3228/4885MMP9 4339/4885MMP12 2672/4885 |
| US-20180071304-A1 | Phenoxy Acetic Acids and Phenyl Propionic Acids as PPAR Delta Agonists | PPARG, PPARA, PPARD | MMP2 3228/4885MMP9 4339/4885MMP12 2672/4885 |
| US-20200215073-A1 | PHENOXY ACETIC ACIDS AND PHENYL PROPIONIC ACIDS AS PPAR DELTA AGONISTS | PPARG, PPARA, PPARD | MMP2 3228/4885MMP9 4339/4885MMP12 2672/4885 |
| US-20210188758-A1 | PHENOXY ACETIC ACIDS AND PHENYL PROPIONIC ACIDS AS PPAR DELTA AGONISTS | PPARG, PPARA, PPARD | MMP2 3228/4885MMP9 4339/4885MMP12 2672/4885 |
| US-20120264980-A1 | LIQUID CRYSTAL OLIGOMER, SYNTHESIS COMPOSITION, PREPARATION METHOD THEREOF, AND LIQUID CRYSTAL MATERIAL | RNMT, DNMT3A, DNMT1 | MMP2 3765/4885MMP9 3195/4885MMP12 4740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.